A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease

Clinical trial NCT03765762 · COMPLETED

Trial details

NCT number: NCT03765762
Sponsor: Alkahest, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Alzheimer Disease

Start date: 2019-01-15
Primary completion: 2019-12-17
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.